Cargando…

Spirometry parameters used to define small airways obstruction in population-based studies: systematic review

BACKGROUND: The assessment of small airways obstruction (SAO) using spirometry is practiced in population-based studies. However, it is not clear what are the most used parameters and cut-offs to define abnormal results. METHODS: We searched three databases (Medline, Web of Science, Google Scholar)...

Descripción completa

Detalles Bibliográficos
Autores principales: Knox-Brown, Ben, Mulhern, Octavia, Feary, Johanna, Amaral, Andre F. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939095/
https://www.ncbi.nlm.nih.gov/pubmed/35313875
http://dx.doi.org/10.1186/s12931-022-01990-2
_version_ 1784672674024259584
author Knox-Brown, Ben
Mulhern, Octavia
Feary, Johanna
Amaral, Andre F. S.
author_facet Knox-Brown, Ben
Mulhern, Octavia
Feary, Johanna
Amaral, Andre F. S.
author_sort Knox-Brown, Ben
collection PubMed
description BACKGROUND: The assessment of small airways obstruction (SAO) using spirometry is practiced in population-based studies. However, it is not clear what are the most used parameters and cut-offs to define abnormal results. METHODS: We searched three databases (Medline, Web of Science, Google Scholar) for population-based studies, published by 1 May 2021, that used spirometry parameters to identify SAO and/or provided criteria for defining SAO. We systematically reviewed these studies and summarised evidence to determine the most widely used spirometry parameter and criteria for defining SAO. In addition, we extracted prevalence estimates and identified associated risk factors. To estimate a pooled prevalence of SAO, we conducted a meta-analysis and explored heterogeneity across studies using meta regression. RESULTS: Twenty-five studies used spirometry to identify SAO. The most widely utilised parameter (15 studies) was FEF(25–75), either alone or in combination with other measurements. Ten studies provided criteria for the definition of SAO, of which percent predicted cut-offs were the most common (5 studies). However, there was no agreement on which cut-off value to use. Prevalence of SAO ranged from 7.5% to 45.9%. As a result of high heterogeneity across studies (I(2) = 99.3%), explained by choice of spirometry parameter and WHO region, we do not present a pooled prevalence estimate. CONCLUSION: There is a lack of consensus regarding the best spirometry parameter or defining criteria for identification of SAO. The value of continuing to measure SAO using spirometry is unclear without further research using large longitudinal data. PROSPERO registration number CRD42021250206 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-01990-2.
format Online
Article
Text
id pubmed-8939095
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89390952022-03-23 Spirometry parameters used to define small airways obstruction in population-based studies: systematic review Knox-Brown, Ben Mulhern, Octavia Feary, Johanna Amaral, Andre F. S. Respir Res Research BACKGROUND: The assessment of small airways obstruction (SAO) using spirometry is practiced in population-based studies. However, it is not clear what are the most used parameters and cut-offs to define abnormal results. METHODS: We searched three databases (Medline, Web of Science, Google Scholar) for population-based studies, published by 1 May 2021, that used spirometry parameters to identify SAO and/or provided criteria for defining SAO. We systematically reviewed these studies and summarised evidence to determine the most widely used spirometry parameter and criteria for defining SAO. In addition, we extracted prevalence estimates and identified associated risk factors. To estimate a pooled prevalence of SAO, we conducted a meta-analysis and explored heterogeneity across studies using meta regression. RESULTS: Twenty-five studies used spirometry to identify SAO. The most widely utilised parameter (15 studies) was FEF(25–75), either alone or in combination with other measurements. Ten studies provided criteria for the definition of SAO, of which percent predicted cut-offs were the most common (5 studies). However, there was no agreement on which cut-off value to use. Prevalence of SAO ranged from 7.5% to 45.9%. As a result of high heterogeneity across studies (I(2) = 99.3%), explained by choice of spirometry parameter and WHO region, we do not present a pooled prevalence estimate. CONCLUSION: There is a lack of consensus regarding the best spirometry parameter or defining criteria for identification of SAO. The value of continuing to measure SAO using spirometry is unclear without further research using large longitudinal data. PROSPERO registration number CRD42021250206 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-01990-2. BioMed Central 2022-03-21 2022 /pmc/articles/PMC8939095/ /pubmed/35313875 http://dx.doi.org/10.1186/s12931-022-01990-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Knox-Brown, Ben
Mulhern, Octavia
Feary, Johanna
Amaral, Andre F. S.
Spirometry parameters used to define small airways obstruction in population-based studies: systematic review
title Spirometry parameters used to define small airways obstruction in population-based studies: systematic review
title_full Spirometry parameters used to define small airways obstruction in population-based studies: systematic review
title_fullStr Spirometry parameters used to define small airways obstruction in population-based studies: systematic review
title_full_unstemmed Spirometry parameters used to define small airways obstruction in population-based studies: systematic review
title_short Spirometry parameters used to define small airways obstruction in population-based studies: systematic review
title_sort spirometry parameters used to define small airways obstruction in population-based studies: systematic review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939095/
https://www.ncbi.nlm.nih.gov/pubmed/35313875
http://dx.doi.org/10.1186/s12931-022-01990-2
work_keys_str_mv AT knoxbrownben spirometryparametersusedtodefinesmallairwaysobstructioninpopulationbasedstudiessystematicreview
AT mulhernoctavia spirometryparametersusedtodefinesmallairwaysobstructioninpopulationbasedstudiessystematicreview
AT fearyjohanna spirometryparametersusedtodefinesmallairwaysobstructioninpopulationbasedstudiessystematicreview
AT amaralandrefs spirometryparametersusedtodefinesmallairwaysobstructioninpopulationbasedstudiessystematicreview